SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000939798-17-000100
Filing Date
2017-12-01
Accepted
2017-12-01 17:25:39
Documents
1
Period of Report
2017-09-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2095
  Complete submission text file 0000939798-17-000100.txt   3760
Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602
Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1623 31ST STREET NW WASHINGTON DC 20007
Business Address
Clarence-Smith Kathleen (Reporting) CIK: 0001721625 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-08092 | Film No.: 171234986